Is hemodiafiltration ready for broader use?
نویسندگان
چکیده
منابع مشابه
Is the Ki-67 labelling index ready for clinical use?
editorial Is the Ki-67 labelling index ready for clinical use? Cancer is one of the leading causes of death worldwide. Identification of biomarkers that can detect cancer early, monitor disease progression or serve as a surrogate marker for prognosis and prediction will enable us to personalise medicine and improve care of cancer patients. Up to now, the leading parameters that define treatment...
متن کاملThree-dimensional echocardiography: is it ready for everyday clinical use?
O 3 A w t s a s t w a 3 T p r f s t has shown its mettle in the accurate meaurement of left ventricular mass, volumes, nd ejection fraction. It has been used sucessfully in the careful assessment of valvular eart disease. An ideal application is in mitral alve disease, especially in operating room cenarios before mitral valve repair, to aid the ardiac surgeon in surgical planning. Congental hea...
متن کاملIs molecular profiling ready for use in clinical decision making?
Molecular profiling, the classification of tissue or other specimens for diagnostic, prognostic, and predictive purposes based on multiple gene expression, is a technology that holds major promise for optimizing the management of patients with cancer. However, the use of these tests for clinical decision making presents many challenges to overcome. Assay development and data analysis in this fi...
متن کاملCounterpoint: clinical neuroscience is not ready for clinical use.
Radical proposals are being made to change the practice, teaching and research basis of psychiatry to that of clinical neuroscience. Such changes would affect practice via what is studied, published, recommended as standard treatment and what is decided in medico-legal forums. These proposed changes are very premature and misguided. Here, I refute these proposals.
متن کاملPeanut oral immunotherapy is not ready for clinical use.
Hippocrates wrote that ‘‘The physician must . . . have two special objects in view with regard to disease, namely, to do good or to do no harm’’ (Hippocratic Corpus, Epidemics, Bk I, Sect 5). As physicians, we are continually challenged with the task of weighing the possible risks and benefits of treatment against those of taking no action. Similarly, we pursue clinical investigation when exist...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kidney International
سال: 2015
ISSN: 0085-2538
DOI: 10.1038/ki.2015.251